Control of endogenous cell regulators by the second-stage tumor promoter phorbol-12-retinoate 13-acetate
- 15 April 1983
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 31 (4) , 497-500
- https://doi.org/10.1002/ijc.2910310416
Abstract
The phorbol esters phorbol 12‐retinoate 13‐acetate (RPA) and 12‐O‐tetradecanoyl phorbol 13‐acetate (TPA) were used to investigate the role of tumor promoters in the control of hormone response in normal and leukemic myeloid celts. RPA and TPA inhibited the binding of [20‐3H]phorbol 12,13‐dibutyrate to the leukemic cells in a competitive manner with 50% inhibition values of 5.2±l.3 and 1.1±0.6 nM, respectively. RPA, like TPA, enhanced (1) prostaglandin E,‐induced cyclic AMP synthesis, (2) the differentiation of leukemic cells induced by the normal myeloid differentiation‐inducing protein, and (3) the formation of normal myeloid cells colonies induced by the normal myeloid growth‐inducing protein. Both compounds can thus control endogenous cell regulators. Since RPA functions in the second stage of tumor promotion in mouse skin, it is suggested that the control of such endogenous regulators may involve biochemical pathways similar to those that are activated in the second stage of tumor promotion.This publication has 23 references indexed in Scilit:
- Skin tumor promotion by phorbol esters is a two-stage process.Proceedings of the National Academy of Sciences, 1981
- Regulation of gene expression by tumor promoters. III. Complementation of the developmental program in myeloid leukemic cells by regulating mRNA production and mRNA translationInternational Journal of Cancer, 1981
- Arachidonic acid and prostaglandin E2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell lineCancer Letters, 1981
- Specific binding of phorbol ester tumor promoters to mouse skinCell, 1980
- Tumor Promoters and the Mechanism of Tumor PromotionAdvances in Cancer Research, 1980
- Specific binding of phorbol ester tumor promotersProceedings of the National Academy of Sciences, 1980
- Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.Proceedings of the National Academy of Sciences, 1979
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proceedings of the National Academy of Sciences, 1978
- Control of lysozyme induction in the differentiation of myeloid leukemic cellsCell, 1976
- A Protein Binding Assay for Adenosine 3′:5′-Cyclic MonophosphateProceedings of the National Academy of Sciences, 1970